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Reactive gliosis is a prominent feature of neurodegenerative and neuroinflammatory disease in the CNS, yet the stimuli that drive this
response are not known. There is growing appreciation that signaling through Toll-like receptors (TLRs), which is key to generating
innate responses to infection,may have pathogen-independent roles.We show that TLR2was selectively upregulated bymicroglia in the
denervated zones of the hippocampus in response to stereotactic transection of axons in the entorhinal cortex. In mice lacking TLR2,
there were transient, selective reductions in lesion-induced expression of cytokines and chemokines. Recruitment of T cells, but not
macrophages, was delayed in TLR2-deficient mice, as well as inmice lacking TNFR1 (tumor necrosis factor receptor 1). TLR2 deficiency
alsoaffectedmicroglial proliferative expansion,whereas all of these eventswereunaffected inTLR4-mutantmice.Consistentwith the fact
that responses inknock-outmicehadall returned towild-type levels by 8d, therewasnoevidence for effects onneuronal plasticity at 20d.
These results identify a role forTLR2 signaling in the early glial response tobrain injury, acting as an innatebridge toneuroinflammation.
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Introduction
The CNS responds to injury by initiating inflammatory re-
sponses. Participation of the immune system may be beneficial,
or cause additional pathology (Schwartz, 2003; Jones et al., 2005).
The molecular mechanism of neuronal-immune cross talk re-
mains unclear. There is much interest in whether glial cells me-
diate this communication, specifically in directing leukocyte en-
try to the CNS.
Microglia are resident myeloid cells that constitute the innate
immune system in the CNS. They become rapidly and robustly
activated in response to injury or pathological events in the CNS.
Rapid programs of response have been collectively termed CNS
innate (inherent) responses (Nguyen et al., 2002; Streit et al.,
2004; Hauwel et al., 2005; Owens et al., 2005). They include se-
cretion of cytokines and chemokines that regulate the kinetics
and cellular composition of the inflammatory response, upregu-
lation of cell surface molecules, and expansion of local microglial
populations. This reactive microgliosis is a prominent feature of
neurodegenerative and neuroinflammatory disease (Carson,
2002;Nguyen et al., 2002; Streit, 2004; Streit et al., 2004; Ladeby et
al., 2005a). However, the signals that induce microglia to initiate
innate responses are not defined.
Innate immune responses to infection are initiated by
germline-encoded pattern recognition receptors (PRRs) that sig-
nal immediate response to invariant structures that are expressed
by pathogens, but not the host (Gordon, 2002; Janeway and
Medzhitov, 2002). Among these are Toll-like receptors (TLRs),
an evolutionarily conserved family of PRRs (Gordon, 2002; Jane-
way and Medzhitov, 2002; Akira and Takeda, 2004). TLRs may
also have pathogen-independent roles, by initiating responses to
host-derived, endogenous ligands. Recent in vitro studies have
primarily focused on identifying such ligands for TLR2 and
TLR4, which are best known to recognize bacterial lipoproteins/
peptidoglycan and lipopolysaccharide (LPS), respectively (Gor-
don, 2002; Akira and Takeda, 2004; Tsan andGao, 2004; Rifkin et
al., 2005). However, concern over endotoxin contamination has
made it difficult to confirm whether endogenous signaling ac-
counts for these responses (Tsan and Gao, 2004). Both TLR2 and
TLR4 are constitutively expressed in the CNS (Laflamme et al.,
2001; Bsibsi et al., 2002; Olson andMiller, 2004; Carpentier et al.,
2005; Jack et al., 2005; Kielian, 2006), and may be upregulated in
the absence of pathogenic stimuli (Nguyen et al., 2001; Tanga et
al., 2004; Turrin and Rivest, 2004).
Axonal degeneration in the hippocampus, triggered by stereo-
tactic lesioning of axons in the entorhinal cortex, causes rapid
glial activation without junctional disruption of the blood–brain
barrier (Fagan andGage, 1994; Jensen et al., 1997; Bechmann and
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Nitsch, 2000; Babcock et al., 2003; Ladeby et al., 2005a). Respon-
sive microglia and astrocytes initiate a cascade of events that pro-
mote later chemokine-driven entry of leukocytes from blood
(Babcock et al., 2003).We have addressedwhether TLR2 or TLR4
signaling drives this response.We show that lack of TLR2 reduces
early cytokine and chemokine expression, and delays T cell re-
cruitment andmicroglial proliferative response. These events are
TLR4 independent. Our results point to an endogenous role for
TLR2 signaling in regulating the neuroinflammatory response to
axonal injury.
Materials andMethods
Animals/surgery. TLR2-deficient mice (Werts et al., 2001) were back-
crossed to C57BL/6 for 6–10 generations. C57BL/6-backcrossed tumor
necrosis factor receptor 1 (TNFR1)-deficient mice were maintained as a
colony from breeders originally donated by Dr. Tak Mak (Ontario Can-
cer Institute, Ontario, Canada). Control C57BL/6 mice were purchased
from Charles River Canada (St. Constant, Quebec, Canada) or the The
Jackson Laboratory (Bar Harbor, ME). TLR4-defective C3H/HeJ mice,
which have a point mutation that renders this receptor nonfunctional
(Poltorak et al., 1998), were purchased from The Jackson Laboratory,
and C3H/HeN mice (Charles River Canada) were used as wild-type
(WT) controls. All animals were maintained under specific pathogen-
free conditions according to Canadian Council on Animal Care guide-
lines, as administered by theMcGill University (Montreal, Quebec, Can-
ada) Animal Care Committee. Some TLR2-deficient and C57BL/6 mice
(Taconic, Ry, Denmark) were housed in the Laboratory of Biomedicine
at the University of Southern Denmark.
Under anesthesia, animalswere placed into a stereotactic apparatus for
wireknife transection of axons in the entorhinal cortex, as described
previously (Babcock et al., 2003; Wirenfeldt et al., 2005). Hippocampi
from unmanipulated or sham-operated mice were also analyzed (data
not shown). Mice were perfused with PBS for RNA or flow cytometric
analysis at various times after lesion. For these studies, the control con-
tralateral and the lesion-reactive hippocampi were dissected from indi-
vidual mice. Briefly, a scalpel was used to make an incision between the
two hemispheres of the brain, to a depth that extended through the
cortical layers only. The entire cortexwas lifted andunfolded to each side,
revealing the hippocampi on the exposed surfaces. Small incisions were
made at the level of the fornix, and then the hippocampi were peeled out
using the back of the scalpel blade, with careful removal of the entorhinal
cortex (e.g., site of axonal transection). If attached, the choroid plexus on
the hippocampal surface facing the lateral ventricles was removed by
tracing the scapel blade over the tissue.
For immunohistochemical studies or in situ hybridization, mice were
perfused with PBS, followed by 4% paraformaldehyde (PFA) or Borax-
buffered 4% PFA, respectively. The brain was removed, embedded in
OCT (EMS, Hatfield, PA), and frozen in 2-methylbutane cooled on dry
ice.
Quantitative real-time RT-PCR. RNA was isolated from isolated hip-
pocampus and converted to cDNA as described previously (Babcock et
al., 2003). Quantitative real-time RT-PCR was done using the ABI
PRISM 7700 Sequence Detection System (Applied Biosystems, Foster
City, CA) as described previously for matrix metalloproteinase 12
(MMP12) and 18S (Toft-Hansen et al., 2004), and for newly described
primer (Sigma, Oakville, Ontario, Canada) and FAM-MGB Probe (Ap-
pliedBiosystems) sequences. Thesewere TLR2 (forward, CTGGAGCAT
CCGAAT TGCAT; reverse, GTT TGCTGAAGAGGACTGTTATGG;
probe, CCT CAG ACA AAG CGT CA), TLR4 (forward, CTC TGA TCA
TGGCACTGTTCTTCT; reverse, TCTGATCCATGCATTGGTAGG
T; probe, CTG CAT AGA GGT AGT TCC), TLR1 (forward, GTT TTA
ATG AGT GTT TGT GAA TGC AGT T; reverse, ATT CCT GAG GTC
CCTGCTATTCTT; probe, CTACAGAAACGTCCTATACC), CD14
(forward, TTT CAG AAT CTA CCG ACC ATG GA; reverse, TCT GGC
GTG CAC CAG AAG CA; probe, CGT GTG CTT GGC TTG), myeloid
differentiating factor 88 (MyD88) (forward, CAG ACA GAC TAT CGG
CTT AAG TTG TG; reverse, TCT GTA GAT AAT CGT CAG AAA CAA
CCA; probe, GCT AAT TGAGAAAAGGTG TC), CCL2 (forward, TCT
GGG CCT GCT GTT CAC A; reverse, CCT ACT CAT TGG GAT CAT
CTTGCT; probe, CTC AGCCAGATGCAGTT), tumor necrosis factor
 (TNF) (forward, CCA AAT GGC CTC CCT CTC AT; reverse, TCC
TCC ACT TGG TGG TTT GC; probe, CTC ACA CTC AGA TCA T),
CXCL10 (forward, GCC GTC ATT TTC TGC CTC AT; reverse, GGC
CCG TCA TCG ATA TGG; probe, GGA CTC AAG GGA TCC),
interleukin-1 (IL-1) (forward, CTT GGGCCT CAA AGGAAAGAA;
reverse, AAG ACA AAC CGT TTT TCC ATC TTC; probe, AGC TGG
AGA GTG TGG AT), and CCL5 (forward, GGA GTA TTT CTA CAC
CAG CAG CAA; reverse, CAC ACA CTT GGC GGT TCC TT; probe,
TGC AGT CGT GTT TGT C). The specificity of our primers and probes
was confirmed by sequence homology search using BLAST (basic local
alignment search tool) (www.ncbi.nlm.nih.gov/BLAST/). Primer–probe
sets were designed to span introns to not pick up genomic signal. A
higher primer concentration was used for the IL-1 reaction only
(800 nM).
In situ hybridization. TLR2 and IB cells were localized to the
lesion-reactive hippocampus using radioactive-labeled TLR2-specific
probes, as described previously (Laflamme et al., 2001). To identify the
source of TLR2, sections were additionally stained with anti-iba1 to label
microglia/macrophages (Laflamme et al., 2001).
RNase protection assay. RNase protection assays (RPAs) were per-
formed as described previously (Babcock et al., 2003) using the mCK-5c
template (BDBiosciences,Mississauga, Ontario, Canada) and15g of
RNA from individual, isolated contralateral and lesion-reactive hip-
pocampi, at 3 and 24 h after lesion.
Flow cytometry. Homogenates of individual microdissected hip-
pocampi were prepared as described previously, using a protocol that did
not select for cells of particular buoyant density (Babcock et al., 2003;
Wirenfeldt et al., 2005). Antibodies to CD45 and CD11b or T cell recep-
tor  (TCR) (BD Biosciences) were used to stain for microglia/macro-
phages or T cells, respectively. Microglia were distinguished from mac-
rophages based on lower levels of CD45 (Sedgwick et al., 1998; Babcock et
al., 2003). Biotinylated rat anti-mouse monoclonal antibody specific for
TLR2 (clone 6C2; eBioscience, SanDiego, CA) or isotype control (IgG2b;
BD Biosciences) were detected using allophycocyanin-conjugated
streptavidin (BD Biosciences). Data was collected on a FACScan or a
FACSCalibur and analyzed using CellQuest Pro (BD Biosciences). Total
cell numbers were calculated by adjusting for the fraction of the sample
collected (determined by measuring the sample volume before and after
acquisition).
Stringent guidelines were adopted for detection of rare events. The
total number of events collected for each sample was 1–3 million events
before forward-scatter (FSC)/side-scatter (SSC) gating. The flow cytom-
eter was thoroughly washed between samples. Positive staining was de-
termined based on fluorescence levels compared with isotype controls
(BD Biosciences) or autofluorescence controls. Specifically, cells stained
with CD45 only or CD45 in conjunction with isotype controls for TCR
or CD11b were used to identify the background fluorescence and/or
nonspecific binding of the CD45high population. This approach was
taken because of the high level of autofluorescence observed in the
CD45dim microglial population (Babcock et al., 2003; Wirenfeldt et al.,
2005). The amount of antibody added was carefully titrated, such that
essentially no background staining was evident in these isotype controls.
The variance between replicate runs of the same sample was estimated to
be as low as 0.012% (SD).
For assessment of proliferative response at 24 h and 8 d after lesion, 90
mg/kg 5-bromo-2-deoxyuridine (BrdU) (BD Biosciences) was admin-
istered intraperitoneally to C57BL/6 and TLR2-deficient mice, at 24, 16,
and 8 h before killing. Single-cell suspensions of isolated hippocampi
were prepared and resuspended in HBSS with 2% fetal calf serum
(Sigma) containing 2 g/ml Fc Block (BD Biosciences), 50 g/ml ham-
ster IgG (Jackson ImmunoResearch,West Grove, PA), and 0.1% sodium
azide. Cells were stained for surface markers using antibodies against
CD11b and CD45 (BD Biosciences), and then fixed and stained with
anti-BrdU, per themanufacturer’s instructions (BDBiosciences). For the
8 d analysis, cells were simultaneously additionally labeled with anti-
human glial fibrillary acidic protein (GFAP), which cross-reacts with
mouse GFAP (Invitrogen, San Diego, CA) or an IgG1 isotype control
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(Caltag Laboratories, Burlingame, CA). Mice that had been lesioned but
not injected with BrdU served as negative controls.
The physical properties of cell populations was examined by compar-
ing FSC and SSC properties of cells in contralateral and lesion-reactive
hippocampi. FSC/SSC plots were gated to show only CD11bCD45dim
(microglial) or GFAP (astroglial) cells. GFAP astrocytes did not ex-
press CD11b or CD45, as expected. Dead cells were excluded via FSC
threshold. Scatter intensities were calculated using CellQuest Pro and are
reported as percentage increases in the lesion-reactive hippocampus ver-
sus the contralateral hippocampus isolated from the samemouse at 24 h,
2 d, 5 d, or 8 d after lesion.
Immunohistochemistry. For staining TLR2 on glial cells, 8–10 m sec-
tions were blocked for nonspecific staining using 10% FCS in PBS for 30
min at room temperature. Sections were incubated overnight with bio-
tinylated rat anti-TLR2 (6C2; eBioscience) in blocking buffer, at 4°C.
This antibody did not stain TLR2-deficient tissues (supplemental Fig.
1B, available at www.jneurosci.org as supplemental material). After ex-
tensive washing (PBS plus 1% Triton X-100), sections were incubated
with biotinylated goat anti-rat antibody (GE Healthcare, Hillerød, Den-
mark) at room temperature for 1 h, followed by streptavidin-conjugated
alkaline phosphatase (DakoCytomation, HighWycombe, UK) for 1 h at
room temperature. TLR2 expression was visualized using a Vector Red
substrate kit (Vector Laboratories, Burlingame, CA) according to the
manufacturer’s instructions. For double staining, rabbit anti-iba1
(DakoCytomation) or rabbit anti-GFAP (DakoCytomation) was added
at 4°C overnight. These antibodies were detected using Alexa 488-
conjugated donkey anti-rabbit antibody (Invitrogen), subsequent to ex-
tensive washing. Sections weremounted usingGelvatol and viewed using
an Olympus (Tokyo, Japan) BX51 microscope. Control sections stained
using rat anti-IgG2b (BD Biosciences) at the same concentration as the
TLR2 antibody, or anti-TLR2 followed by 1% rabbit serum, showed no
staining.
ForCD45 andCD11b staining, 10- to 12-m-thick horizontal cryostat
sections were adhered to SuperfrostD/Plus slides (Fischer Scientific,
Montreal, Quebec, Canada), fixed in 4% PFA, and then incubated in 1%
Triton X (20 min each). Sections were blocked for nonspecific staining
using 20% normal goat serum in PBS, and then for endogenous biotin
using an avidin–biotin kit (Vector). Primary rat anti-CD11b (Serotec,
Hornby, Ontario, Canada), rat anti-CD45 (Serotec), or rat anti-GFAP
(Zymed, Markham, Ontario, Canada) antibodies were added at room
temperature for 1 h, and then a biotinylated rabbit anti-rat secondary
antibody (Vector Laboratories) was applied for 45 min. Control sections
stained using rat anti-IgG2b (Serotec) or rat IgG (Jackson Immuno-
Research) at the same concentration as the primary antibodies showed
no fluorescence. Alexa 555-conjugated streptavidin (Invitrogen) was
used to visualize the staining on a Leica (Nussloch, Germany) DMIRE2
microscope, after being counterstained with 0.01% Hoechst dye
(Invitrogen).
Enzymatic staining for acetylcholinesterase (AChE) was performed on
perfusion-fixedmaterial using a modification of the thiocholine method
(Drojdahl et al., 2002). Degenerating fibers and terminals were visualized
in parallel sections using Fluoro-Jade (Histo-Chem, Jefferson, AR)
(Nguyen et al., 2001).
Results
Microglia upregulate TLR2 in response to axonal injury
TLR2 was constitutively expressed in the hippocampus, because
mRNA was easily detectable in unmanipulated and contralateral
hippocampus by quantitative RT-PCR (Fig. 1A) (data not
shown). After axonal injury, TLR2 mRNA was significantly up-
regulated in the lesion-reactive hippocampus by 3 h, relative to
the unlesioned hippocampus in the contralateral hemisphere of
the brain (Fig. 1A). We localized TLR2 cells to the molecular
layers of the hippocampus, where axons and terminals break
down and glia become activated, showing positive signal by in situ
hybridization (ISH) at 3 h (supplemental Fig. 1A, available at
www.jneurosci.org as supplemental material), and by fluores-
cence microscopy at 3 d (Fig. 1E–H; supplemental Fig. 1B, avail-
Figure 1. TLR2 is upregulated by microglia in denervated zones of the hippocampus. A,
Levels of TLR2 mRNA, measured by quantitative RT-PCR and normalized to 18S, were
increased in lesion-reactive hippocampi (L) from C57BL/6 mice relative to contralateral
hippocampi (C) at 3 h (n 10). Results are expressed as mean SE. B, Flow cytometric
quantification of percentage CD11bCD45 dim microglia from contralateral (C) and
lesion-reactive (L) hippocampi that stained with a monoclonal antibody specific for TLR2
24 h after lesion (n 4). Asterisks in A and B indicate statistically significant differences
between C and L ( p 0.05). C, Representative histogram overlay shows positive staining
with anti-TLR2 of CD11bCD45 dimmicroglia from lesion-reactive hippocampus (L) (black
profiles) versus staining of microglia from contralateral hippocampus (C) (dark gray pro-
files), relative to background staining with an IgG2b isotype control antibody (light gray
profiles). D, Similar to C except that TLR2 staining was gated on GFAP cells. E, G,
Immunofluorescence photomicrographs of the outer molecular layer of the dentate gyrus
from a lesion-reactive hippocampus, stained with anti-iba-1 (green) and anti-TLR2 (red),
3 d after lesion. The zone of glial reactivity is clearly defined by reactive iba-1microglia.
Many of these are double stained for TLR2, with the combined green and red fluorescence
shown as yellow (2 examples are indicated by arrows). F, H, Similar to E, G, except that
reactive astrocytes are stained in green with anti-GFAP. Reactive astrocytes and microglia
define an overlapping zone of glial response. Reactive astrocytes do not double stain with
anti-TLR2, because green and red cells do not coincide. The arrows indicate two examples
of TLR2 (red) cells that do not express GFAP. Original magnifications: E, F, 10;
G, H, 40.
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able at www.jneurosci.org as supplemental material). Flow cyto-
metric staining showed that CD11bCD45dim microglial cells
upregulated TLR2 at 24 h after lesion, relative to the contralateral
hippocampus (Fig. 1B,C) or unmanipulated hippocampus or
cortex (data not shown), and that GFAP-positive cells did not
upregulate TLR2 (Fig. 1D). TLR2-expressing cells were identified
as microglia in tissue sections by double immunofluorescent
staining with iba-1 (Fig. 1E,G). Although not all of the iba-1-
positive cells (Fig. 1E,G, green cells) in the region of glial re-
sponse stained positive for TLR2, it appeared that only microglia
expressed TLR2, because there were no red cells that did not
coincide with green (Fig. 1E,G). Importantly, there was no de-
tectable double staining with anti-GFAP antibody (Fig. 1F,H).
The greater sensitivity of flow cytometry accounts for the shift in
staining of the whole microglial population in Figure 1C, not just
the high expressing cells that were detected by immunofluores-
cence in Figure 1E. TLR2-stained cells were undetectable by flu-
orescencemicroscopy in the contralateral unlesioned hippocam-
pus (data not shown), and only weak staining was detected by
flow cytometry (Fig. 1B,C). Given this greater sensitivity, the lack
of signal by flow cytometry underlines that, in this system, astro-
cytes did not upregulate TLR2.
We also examined the expression of other surface molecules
and intracellular proteins associated with signaling through
TLR2. Both TLR1, which, like TLR6, can dimerize with TLR2,
and CD14, a coreceptor for either TLR2 or TLR4 (Ozinsky et al.,
2000;Werts et al., 2001; Asea et al., 2002; Akira andTakeda, 2004)
were constitutively expressed and upregulated after axonal injury
(supplemental Fig. 1C,D, available at www.jneurosci.org as sup-
plemental material). TLR12 heterodimer signaling is impli-
cated in inflammatory cytokine responses (Sandor et al., 2003).
TLR6 expression was not examined. Detection of MyD88 and
IB mRNA by quantitative RT-PCR and ISH, respectively,
(supplemental Fig. 1E,F, available at www.jneurosci.org as sup-
plemental material), is consistent with downstream signaling by
TLRs in microglia at these times, although these intermediates
may also be involved in other signaling pathways.
The early increase in TLR2 expression bymicroglia pointed to
a specific role for TLR2 in directing the neuroinflammatory re-
sponse to axonal injury, and prompted us to examine responses
in TLR2-deficient mice.
TLR2 selectively regulates early cytokine and
chemokine expression
We compared early glial cytokine and chemokine expression in
the lesion-reactive hippocampus of C57BL/6 wild-type and
TLR2-deficient mice at 3 h after lesion. There is no significant
infiltration of blood-derived leukocytes to the hippocampus as
early as 3 h (Babcock et al., 2003), so CNS-resident cells are the
most likely sources of cytokines and chemokines at this time.
Rapid upregulation of transcripts for the cytokines TNF (30-
fold increase) and IL-1 (10-fold increase) occurred in the
lesion-reactive hippocampus of wild-type mice, relative to con-
tralateral hippocampi (Fig. 2A). Strikingly, TNF mRNA levels
Figure 2. Selective effects of TLR2 signaling on early cytokine/chemokine expression induced by axonal injury. Cytokine and chemokine transcripts were measured in contralateral (C) and
lesion-reactive (L) hippocampi from WT and TLR2-deficient mice by quantitative real-time PCR (A, C, D, G; n 7–10) or RPA (B, E, F; n 3) at times indicated (3 h, 24 h, or 3 d). Cytokine and
chemokinemRNA levels measured by real-time PCRwere normalized to 18S, and thosemeasured by RPA to levels of L32. Values are expressed as arbitrary units and cannot be compared between
panels. Results are expressed as mean SE. NS, Not statistically significant. *p 0.05.
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were greatly diminished in hippocampi
from TLR2-deficient mice, which ex-
pressed only 30% of levels seen in wild-
type controls (Fig. 2A). TNF levels
remained significantly lower in TLR2-
deficient mice at 24 h (Fig. 2D). IL-1
mRNA levels were similar inwild-type and
TLR2-deficient mice at 3 h (Fig. 2A) and
24 h (data not shown).
We also examined the effects of TLR2
deficiency on early lesion-induced chemo-
kine expression, by RPA. Compared with
wild-type mice, lesion-induced levels of
CCL3, CCL4, CXCL2, and CXCL10
mRNA were significantly reduced in the
absence of TLR2 signaling (Fig. 2B). In
contrast, mRNA levels of the chemokine
CCL2 were similar in hippocampi from
wild-type and TLR2-deficient mice (Fig.
2B). CCL5 levels, which do not show an
early increase after lesion (Babcock et al.,
2003), were also similar in wild-type and
TLR2-deficient mice at 3 h. The chemo-
kines CXCL10 andCCL2 have been specif-
ically implicated in leukocyte entry to the
CNS (Babcock et al., 2003; Christensen et
al., 2004). We confirmed, using quantita-
tive RT-PCR, that expression of CXCL10,
but not CCL2, was reduced in absence of
TLR2 at 3 h (Fig. 2C).
Together, these results show that ab-
sence of TLR2 selectively reduces early cy-
tokine and chemokine responses to axonal
injury.Whereas TNF and several chemo-
kines are significantly dependent on TLR2
signaling, CCL2 and IL-1 are TLR2 inde-
pendent. Cytokine/chemokine expression
is therefore triggered by at least two signal-
ing pathways.
TLR2 regulates T cell infiltration but not
macrophage recruitment
We then examined leukocyte infiltration
in response to axonal degeneration in
TLR2-deficient mice relative to wild-type
controls. We have previously shown that
CCL2-driven macrophage infiltration be-
gins at 12 h after lesion, whereas entry by T
cells starts at 24 h (Babcock et al., 2003). T cells have been stained
in the lesion-reactive hippocampus by others (Bechmann et al.,
2001), aswell as in other lesion-reactive regions of theCNS (Raiv-
ich et al., 1998). Infiltrating cells enter the parenchyma in dener-
vated zones by crossing the glia limitans that surrounds blood
vessels (Bechmann et al., 2005).
The small proportion of CD11bCD45highmacrophages de-
tected in contralateral unlesioned hippocampus rapidly in-
creased in the lesion-reactive hippocampus after axonal injury in
wild-type mice (Fig. 3A,B). This population was clearly distin-
guishable from the resident CD11bCD45dim resident popula-
tion, even by 8 d after axotomy (Fig. 4A, compare top right,
bottom right quadrants) Consistent with previous observations
(Babcock et al., 2003), macrophage proportions peaked in the
lesion-reactive hippocampus of wild-type mice at 2 d, and had
begun to decrease by 5 d (Fig. 3A,B). Macrophage recruitment was
unaffected by TLR2 deficiency. Similar macrophage proportions
were observed in lesion-reactive hippocampi of TLR2-deficient and
wild-typemice at 24h, 2d, 5d, and8d(Fig. 3A,B) (datanot shown).
Analysis of mean numbers (SE) of macrophages also showed no
significant differences between lesion-reactive hippocampi from
wild-type and TLR2-knock-out mice at 24 h (464 135 vs 396
111, respectively) or 8 d (226 23 vs 207 25, respectively), com-
pared with 100 cells detected in contralateral hippocampi (n 
6–9/group). Both strains also showed equivalent upregulation of
macrophage-associated MMP12 mRNA at 24 h (data not shown)
(Toft-Hansen et al., 2004). Together with our observation that early
CCL2 expression isTLR2 independent, these data suggest thatTLR2
does not regulate CCL2-drivenmacrophage infiltration in response
to axonal injury.
Figure 3. TLR2 deficiency delays infiltration by T cells but not macrophages. Flow-cytometric evaluation of the proportion of
CD11bCD45 high macrophages at 2 d (A) and 5 d (B) after lesion in contralateral (C) and lesion-reactive (L) hippocampi showed
nodifferences inmacrophage infiltrationbetweenWTandTLR2-deficient (TLR2KO)mice (n7).C, Flowcytometryprofiles show
an increased proportion of TCRCD45 high T cells (boxes) in lesion-reactive hippocampus (L) versus contralateral hippocampus
(C) at 2 d after lesion. Quantification of proportions of TCR cells at 2 d (D), 5 d (E), and8d (F ) revealeddelayed T cell infiltration
in TLR2-deficient mice (n 6–8). G, Analysis of TNFR1-deficient (TNFR1 KO) mice at 2 and 5 d after lesion shows delayed
lesion-induced T cell recruitment, as for TLR2-deficient mice. Data are presented as T cell proportions in the lesion-reactive
hippocampus relative to the contralateral hippocampus, on an individual mouse basis. Results are expressed as mean SE. NS,
Not statistically significant. *p 0.05.
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Importantly, however, TLR2 deficiency affected the T cell re-
sponse to axonal injury. At 2 d after lesion, T cells consistently
infiltrated the hippocampus of wild-type mice (Fig. 3C,D). This
represented an increase from100 T cells in control hippocampi
to 300 T cells in the lesion-reactive hippocampus. The detec-
tion of a small number of T cells in the contralateral hippocam-
pus is consistent with published reports (Brabb et al., 2000). The
number of T cells that enter would be sufficient to induce biolog-
ical effect, if activated. Consistent with previous observations
(Babcock et al., 2003), T cell proportions declined slightly from 2
to 5 d in wild-type mice (Fig. 3D,E). Unlike wild-type mice,
significant lesion-induced T cell recruitment did not occur in
TLR2-deficient mice at 2 d after lesion (Fig. 3D). TLR2-deficient
mice showed recovery of T cell response by 5 d after lesion (Fig.
3E). T cell proportions were significantly higher in TLR2-
deficient mice than in wild-typemice at 5 d, but were similar to T
cell proportions at 2 d in wild-typemice. At 8 d after lesion, T cell
infiltration remained equivalently elevated in the lesion-reactive
hippocampus of both TLR2-deficient and wild-type mice, and
there was no longer a significant difference in T cell recruitment
between TLR2-deficient and wild-type mice (Fig. 3F). Together,
these data suggest that TLR2 deficiency delays T cell infiltration,
and that macrophage and T cell recruitment are directed by
separate pathways.Whereas TLR2 signaling regulates T cell entry,
macrophage infiltration occurs via a TLR2-independent
pathway.
TNFR1 deficiency mimics effect of TLR2 deficiency on T
cell infiltration
To address mechanism for delayed T cell entry at 2 d, we asked
whether TNF played a role, because this cytokine has been de-
scribed to induce chemokines that promote T cell entry to the
CNS (Murphy et al., 2002).Mice deficient in theTNFR1 receptor,
previously implicated in CNS inflammation (Eugster et al.,
1999), were lesioned, and T cell entry to the hippocampus evalu-
ated at 2 and 5 d after lesion. Results were strikingly similar to
what was observed in TLR2-deficientmice, with a delay in lesion-
induced T cell recruitment at 2 d and a rebound at 5 d (to levels
equivalent to WT at 2 d) (Fig. 3G). Like TLR2-deficient mice,
TNFR1 deficiency also had no effect onmacrophage recruitment
(data not shown). This points to a role for TNF in TLR2 regu-
lation of T cell entry. We then asked whether this might correlate
to potential TNF-driven chemokine responses. Chemokine
RPA data showed that, whereas overall levels of all chemokine
messages were reduced by 24 h (data not shown), levels of CCL4,
reduced in TLR2-deficient mice at 3 h, were now equivalent to
controls (Fig. 2E). CCL4 has been implicated in T cell entry to the
CNS in experimental autoimmune encephalomyelitis (EAE)
(Babcock andOwens, 2003), and is induced in the CNS by TNF
(Glabinski et al., 2003). At 24 h, levels of CXCL10 remained lower
in TLR2-deficient mice, whereas CCL5 levels were equivalent in
knock-out and wild-type mice (Fig. 2F) (data not shown). Addi-
tional analysis by real-time PCR showed that CXCL10 levels be-
came equivalent, and CCL5 levels remained equivalent, in TLR2-
deficient andwild-typemice at 3 d after lesion (Fig. 2G) (data not
shown). Together, these data identify TNF and at least three
chemokines as candidate mediators whose relative levels regulate
early T cell entry in response to injury. Whether these mediators
act via a cascade has not been determined.
TLR2 regulates responses by microglia
Expansion of the microglial population occurs in the lesion-
reactive hippocampus after axonal injury. A number of studies
have shown that this results fromproliferation by residentmicro-
glia, migration into denervated zones, and by differentiation of
blood-derived cells into ramified or CD45dim microglia (Jensen
et al., 1994; Hailer et al., 1999; Rappert et al., 2004; Bechmann et
al., 2005; Ladeby et al., 2005b;Wirenfeldt et al., 2005). Microglial
expansion can be detected using flow cytometry to compare the
proportion of CD45dim microglia in the lesion-reactive hip-
pocampus to that in the contralateral hippocampus (Fig. 4A).
Such analyses identify a statistically significant increase inmicro-
glial expansion by 2 d after lesion (n 16), but not at earlier times
(Fig. 4B). In wild-type mice, the microglial population increased
by 37% at 2 d, reaching a 70% increase after 5 d (Fig. 4B). In
contrast, microglial expansion in hippocampi from TLR2-
deficient mice showed increases of only 16 and 37% at 2 and 5 d,
respectively, significantly less than what was observed in wild-
type controls (Fig. 4B). At 8 d, microgial expansion was equiva-
lent in wild-type and TLR2-deficient mice, both showing in-
creases of60% (63 vs 50%) (Fig. 4B). There was no statistically
significant difference in mean numbers of microglia in lesion-
reactive hippocampi at 8 d (33,857  2148 in wild-type vs
35,000  2166 in TLR2-knock-out, compared with 23,000 in
contralateral hippocampi; n 6–9 per group). Interestingly, mi-
croglial expansion was unaffected in TNFR1-deficient mice at 2
and 5 d (Fig. 4B). The zone of microglial reactivity, clearly delin-
eated in wild-type mice, was less well defined in TLR2-deficient
mice (Fig. 5A,B). Occasional CD11b or CD45 (supplemental
Fig. 2, available at www.jneurosci.org as supplemental material)
cells that can be seen in the dentate gyrus likely include both
macrophages and activated microglia.
We asked whether early microglial responses were also af-
fected by TLR2 signaling, because TLR2 deficiency had a pro-
Figure 4. TLR2 deficiency impairs microglial expansion. A, The proportion of
CD11bCD45 dim microglia increased in lesion-reactive hippocampi (L) from wild-type mice
(WT) relative to contralateral hippocampi (C) after axonal lesion (bottom right quadrants;
shown for 8 d after lesion). Microglia were clearly distinguished from macrophages (m),
which expressed higher levels of CD45 (CD45 high; top right quadrants).B, Quantification shows
that percentage increase in microglial expansion relative to the contralateral hippocampus
became statistically significant from 2 d after lesion and that expansion at 2 and 5 dwas similar
in TNFR1-deficientmice as inWT. Expansionwas significantly reduced in TLR2-deficientmice at
2 and 5 d but returned to WT levels at 8 d (n 5–16, except 90 d where n 2). Results are
expressed as mean SE. *p 0.05.
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found effect on cytokine and chemokine expression within the
first 24 h of injury. Given that bone marrow chimera studies
showed that the CD45dim microglial population was mostly sup-
plemented by immigrating cells after 5 d (Wirenfeldt et al., 2005)
and that migration from adjacent hippocampal zones (Jensen et
al., 1994; Rappert et al., 2004) could not account for observed
effects in entire hippocampal isolates, we asked whether TLR2
deficiency affected microglial proliferation. Lesion-induced pro-
liferation of the CD11bCD45dimmicroglial population became
detectable at 24 h, as measured by BrdU incorporation detected
by flow cytometry (Fig. 6A), approaching statistical significance
inwild-typemice ( p 0.051). In contrast, the number of BrdU
microglia was unchanged in lesioned TLR2-deficient mice ( p
0.459), and the difference in the number of proliferating micro-
glia in the lesion-reactive hippocampus of wild-type and TLR2-
deficient mice was statistically significant (Fig. 6A). Thus, TLR2
signaling regulates early microglial proliferative expansion. By
8 d, both wild-type and TLR2-deficient mice showed equivalent
BrdU-assayed microglial proliferation in the lesion-reactive hip-
pocampus (data not shown), consistent with equivalence in mi-
croglial numbers at this time. Proliferative responses are known
to have mostly subsided by 10 d (Hailer et al., 1999).
Flow cytometry was additionally used to examine physical prop-
erties of themicroglial population at 24 h, because most cell surface
markers areupregulated at later times andglialmorphology in tissue
sections is difficult to quantify.Microglial activation induces charac-
teristic changes in FSC, which correlates with cell size, and SSC,
which is indicative of cellular complexity (e.g., physical characteris-
tics of nucleus, cytoplasm, and membrane) (Sedgwick et al., 1998).
Within 24 h after lesion, increases in population FSC and SSC were
clearly seen inCD11bCD45dimmicroglia fromlesion-reactivehip-
pocampiofwild-typemice (Fig. 6B, compareCandL forwild-type).
Increased microglial FSC/SSC was less pronounced in the lesion-
reactive hippocampus of TLR2-deficient mice (Fig. 6B), and this
difference was statistically significant (Table 1). The FSC/SSC char-
acteristics of microglia were followed through 8 d after lesion
(Table 1). Responses peaked by 2 d in both mice, and had mostly
diminished by 8 d. The transient increase in SSC for TLR2-deficient
microglia at5ddidnot correspond topatternsof cell expansion(Fig.
4B) or FSC characteristics. The TLR2-dependent reduction in mi-
croglial response at 24 h was therefore transient, as were other as-
pects of the injury-induced inflammatory response in TLR2-
deficient mice.
We also examined whether TLR2 signaling regulated re-
Figure 5. TLR2 signaling affectsmicroglial, but not astroglial reactivity in denervated zones.
A–D, CD11b (A, B) and GFAP (C, D) staining in lesion-reactive hippocampi of WT and TLR2-
deficient mice at 5 d after lesion (n 4). The arrows delineate reactive zones. The insets show
high magnification images of microglia and astrocytes from the denervated outer molecular
layer of the dentate gyrus. A, Inset, shows a cell doublet, consistent with proliferation, and an
isolated CD11b cell. The morphology of cells identified by nuclear staining in the inset in B is
less clearly defined because of weak CD11b staining. The GFAP staining shows the well defined
laminar organization of glial response characteristic of the entorhinal lesion. Original magnifi-
cation, 10 and 40.
Figure 6. TLR2 deficiency impairs early microglial response. A, Microglial proliferation was
assessed by BrdU incorporation by CD11bCD45 dim microglia in the lesion-reactive (L) and
contralateral (C) hippocampi of WT and TLR2-deficient (TLR2 KO) mice at 24 h. Results are
expressed as mean SE. *p 0.05. B, The physical properties of microglial populations in
contralateral and lesion-reactive hippocampi are shown on FSC/SSC dot plots, which are gated
on CD11bCD45 dim (microglial) cells.
Table 1. FSC and SSC changes in themicroglial population after axonal lesion
24 h 2 d 5 d 8 d
% Increase FSC
WT 9.7 0.8 22.6 1.4 8.3 1.1 3.5 1.1
TLR2 KO 5.5 1.0* 22.7 3.2 7.0 1.6 5.5 0.7
% Increase SSC
WT 10.2 1.7 33.9 3.0 19.4 1.1 6.5 2.0
TLR2 KO 4.8 1.6* 33.9 5.2 25.8 2.9* 7.1 1.7
Values are expressed as a percentage increase in the scatter intensity of the microglial population in the lesion-
reactive hippocampus relative to the contralateral hippocampus at various times after lesion (mean SE). The
asterisks indicate statistically significant differences betweenWT and TLR2-deficient (TLR2 KO) mice.
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sponses by astrocytes. Astrocytes did not upregulate TLR2, and
astroglial activation appeared similar in wild-type and TLR2-
deficient mice, based on the reactivity of GFAP cells in dener-
vated zones (Fig. 5C,D). Astrocyte proliferation in denervated rat
hippocampus peaks at 7 d, later than the microglial peak (Hailer
et al., 1999). Flow cytometric analysis of BrdU incorporation and
FSC/SSC changes by GFAP-stained cells at 8 d indicated that
astrocyte proliferation was detectable, as an approximate dou-
bling of the number of BrdUGFAP cells and an increase in
FSC and SSC, but that neither of these indices of astrogliosis was
affected by TLR2 deficiency (supplemental Fig. 3, available at
www.jneurosci.org as supplemental material).
TLR2 does not influence the lesion-induced reorganization of
AChE-positive fibers
To determinewhether TLR2 deficiency affected neuronal plastic-
ity, we stained AChE-positive septohippocampal fibers that are
left intact by the lesion. Increased intensity of AChE, found in
cholinergic fibers, in the outer molecular layer of the dentate
gyrus is associated with a postlesional plasticity response (Stew-
ard, 1992; Fagan and Gage, 1994; Drojdahl et al., 2002). At both
5 d (data not shown), before this response is easily detectable, and
at 20 d after axotomy (Fig. 7A,B), when the response is well
developed, there was no difference in the lesion-induced increase
in AChE intensity in the dentate gyrus of TLR2-deficient and
wild-type mice. In addition, the distribution of AChE-positive
fibers was similar in unmanipulated dentate gyrus from TLR2-
deficient and wild-type mice (Fig. 7C,D). We confirmed that
lesion-induced neuronal pathology was equivalent in wild-type
and knock-out mice using Fluoro-Jade staining of degenerating
axons and terminals (data not shown).
TLR4 signaling does not regulate the innate response to
axonal injury
We then addressedwhether the neuroinflammatory responsewas
regulated by signaling through TLR4, which we found to be con-
stitutively expressed in the hippocampus but not upregulated
after axonal injury (Fig. 8A). Expression of TNF (Fig. 8B) and
CXCL10 (data not shown), both reduced by TLR2 deficiency,
were not significantly different in hippocampi from TLR4-
defective mice and their wild-type controls. CCL2 was also unaf-
fected by TLR4 deficiency (Fig. 8C). There was no difference in
infiltration by T cells or macrophages at 1, 2, or 5 d after lesion,
and no inhibition of microglial expansion at 5 d (Fig. 8D–F)
(data not shown). Therefore, TLR4 signaling does not appear to
regulate the endogenous hippocampal glial response to entorhi-
nal axonal lesion.
Discussion
We have identified a role for TLR2 in the initial microglial re-
sponse to axonal injury. We show that endogenous signaling by
TLR2, but not TLR4, strongly impacts early glial cytokine and
chemokine responses, and controls kinetics of T cell recruitment
and of reactivity/expansion of the microglial population. Our
data identify two pathways for initial response to axonal injury:
(1) TLR2-dependent regulation of microglial response and T cell
recruitment, and (2) TLR2-independent macrophage entry
and astrocyte response (supplemental Fig. 4, available at www.
jneurosci.org as supplemental material).
There ismuch interest in the role of TLRs in the CNS (Kielian,
2006). TLR2 signaling has been implicated in microglial re-
sponses such as are associated with repair via clearance of myelin
debris in the denervated hippocampus (Bechmann and Nitsch,
2000; Drojdahl et al., 2002; Fenger et al., 2006). Phagocytes were
shown to contain the TLR2 ligand peptidoglycan withinmultiple
sclerosis lesions (Schrijver et al., 2001), and to use the TLR2/4
coreceptor CD14 to bind and phagocytose fibrillar -amyloid
(Fassbender et al., 2004; Liu et al., 2005), making CD14 and TLRs
potential therapeutic targets in the injured or diseased CNS. De-
fects in phagocytic clearancemechanisms are implicated in failed
CNS regeneration (Steward, 1992; David and Lacroix, 2003) and
in amyloid plaque-induced neurotoxicity (Streit, 2004). Consis-
tent with the transient effects of TLR2, we detected no changes in
long-term reorganization of AChE-containing, cholinergic
septo-hippocampal fibers and terminals in the lesion-reactive
dentate gyrus. However, this does not preclude that TLR2 might
influence neuronal survival, regeneration, or neurogenesis in
other models, and indeed TLR ligands exert both beneficial and
pathological effects in the CNS. Administration of the TLR2 li-
gand zymosan promoted regeneration after optic nerve crush
injury (Leon et al., 2000), and systemic injection of the TLR4
ligand LPS acceleratedmyelin clearance in the injured spinal cord
(Vallieres et al., 2005). Intrahippocampal LPS injections en-
hanced-amyloid clearance in aged transgenicmice that develop
Alzheimer’s disease-like pathology (DiCarlo et al., 2001;Malm et
al., 2005), although contradictory results were obtained in
younger mice (Qiao et al., 2001). In contrast, direct injection of
TLR ligands into the healthy brain or spinal cord induced robust
inflammation that caused tissue damage and, in some cases, be-
havioral deficits (Szczepanik et al., 1996; Fitch et al., 1999; Popo-
vich et al., 2002). TLR4 and TLR9 ligands may mediate neuronal
and oligodendrocyte injury indirectly, via effects on microglia
(Lehnardt et al., 2002, 2003; Iliev et al., 2004).
The selective effects of TLR2 deficiency in our study are of
interest. It is tempting to ascribe the selective effects on leukocyte
entry (viz., delayed T cell infiltration without effect on macro-
phage recruitment) to specific regulation of glial cytokine/che-
mokine expression. Our finding that TLR2 signaling impacts ex-
pression of several chemokines, but not CCL2, mirrors findings
Figure 7. TLR2 deficiency has no effect on lesion-induced plasticity of AChE-positive cholin-
ergic afferents. AChE staining of lesion-reactive (top panels) and unlesioned contralateral (bot-
tom panels) hippocampus fromWT (A, C) and TLR2-deficient (TLR2 KO) (B,D) mice. The arrow-
headsdelineate the characteristic lesion-induced increase inAChE staining intensity in the inner
part of the outer molecular layer of the dentate gyrus (DG), and in the molecular layer (m) of
CA3. AChE staining is similar in TLR2-deficient andwild-typemice, 20 d after lesion.ml, Dentate
molecular layer; m, stratummoleculare of CA3. Original magnification, 10.
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in dendritic cells (Re and Strominger,
2001) and cultured microglia (Olson and
Miller, 2004). Leukocyte infiltration was
previously shown to be dependent on
CCL2 signaling through its receptor,
CCR2 (Babcock et al., 2003) (A. A. Bab-
cock and T. Owens, unpublished observa-
tions). Cytokines such as IL-1 that were
unaffected by TLR2 deficiency also may
have contributed to macrophage entry.
The identity of TLR2-regulated chemo-
tactic signal(s), and whether they are di-
rectly induced by TLR2 signaling or indi-
rectly via cytokines such as TNF, is of
interest. That an identical delay in T cell
entry was seen in TNFR1- and TLR2-
deficient mice points to a role for TNF.
The TNFR1 receptor is implicated in
transducing TNF-induced proinflam-
matory signals (Eugster et al., 1999). An
analogous delay in chemokine induction
and T cell entry has been described in
TNF-deficient mice with EAE (Murphy
et al., 2002). Because TNF and a number
of chemokines (CXCL10, CXCL2, CCL3,
CCL4) were significantly reduced, but not
completely ablated in TLR2-deficient
mice, it is also possible that residual lower
cytokine and/or chemokine levels pro-
voked eventual T cell recruitment, to re-
store T cell response by 5 d. Alternatively,
compensatory signals may restore chemo-
kine levels at later times, as was seen for
CCL4 (24 h) and CXCL10 (3 d), and this
recovery may contribute to rebound of T
cell entry. CXCL10 is a strong candidate for recruiting T cell
response (Dufour et al., 2002; Christensen et al., 2004). Activated
T cells express the CXCL10 receptor, CXCR3. Studies in EAE
suggest that other CXCR3 ligands (CXCL9 and CXCL11) may
compensate for CXCL10 deficiency (Klein et al., 2004); however,
these were not induced after entorhinal cortex lesion (Rappert et
al., 2004). CCL4, CCL3, and CCL5 likely do not mediate T cell
recruitment via the CCR5 receptor, which we have shown to be
unnecessary (Babcock et al., 2003), but could potentially affect T
cell recruitment via CCR1. CCL5 is important for T cell traffick-
ing and was unaffected by TLR2 deficiency. Upregulation of
CXCL2 was TLR2 dependent, although CXCL2 predominantly
acts onneutrophils (Babcock andOwens, 2003). In the absence of
detailed information on the cellular source of each cytokine and
chemokine, a model based on direct effects of TLR2-expressing
microglia must remain speculative, although we did not identify
any other TLR2-expressing cell type. Finally, regulation of levels
of expression of adhesion molecules that guide T cell entry to the
CNS may also have played a role.
TLR2 signaling also regulated early stagemicroglial activation
and expansion after injury, but its effect was only transient. The
kinetics of response suggested that TLR2 regulated proliferation,
rather than in entry of circulating precursors (Hailer et al., 1999;
Bechmann et al., 2005; Ladeby et al., 2005b; Wirenfeldt et al.,
2005). Immunohistochemical studies in rats suggested that mi-
croglial proliferation begins at 24 h (Fagan and Gage, 1994),
and we showed that lesion-induced microglial proliferation was
significantly reduced in TLR2-deficient mice at this time, com-
paredwithwild-typemice.We also noted that changes in physical
properties of the microglial population at 24 h were inhibited by
TLR2 deficiency. Microglia stimulated with the TLR2 ligand li-
poteichoic acid developed ruffledmembranes and proliferated in
vitro (Jiang-Shieh et al., 2005), so it is also possible that lack of
direct TLR2-induced nuclear factor B (NFB) signaling con-
tributed to reduced microglial activation/proliferation. The lack
of effect of TNFR1 deficiency onmicroglial response is consistent
with that interpretation, because TNFR1 can signal via an NFB-
independent pathway, and also with other results in the same
lesion model (Fenger et al., 2006). We do not know whether
TLR2 associates with TLR1 or TLR6 for the responses we have
studied. Restoration of microglial response in the case of direct
TLR2 signaling would bemost economically explained by redun-
dancy in TLR signals. Recovery of levels of microglial-activating
chemokines may restore microglial numbers at 8 d, just as for T
cells. Additional studies should resolve these issues.
Microglia constitutively expressed TLR2 and rapidly upregu-
lated this receptor after axonal injury. The kinetics of response
suggests that early effects on TNF and chemokine expression
were attributable to constitutive TLR2 expression. Both astro-
cytes and microglia have been shown to express TLRs in vitro
(Olson andMiller, 2004; Carpentier et al., 2005; Jack et al., 2005).
However, by immunofluorescence microscopy and flow cytom-
etry, we failed to find evidence that astrocyte responses showed
TLR2 dependence, unlike for microglia. Upregulation of TLR2
after axonal lesion may enhance microglial responses to degen-
Figure8. TLR4 signaling does not regulate innate responses to axonal injury. Quantitative RT-PCR showingno increase in TLR4
mRNA in lesion-reactive (L) versus contralateral (C) hippocampi in C57BL/6 (WT)mice (n 9) (A), and no difference in TNF (B)
or CCL2 (C) levels between C3H/HeJ (TLR4-defective) and C3H/HeN (WT)mice at 3 h after lesion, after normalization to 18S. Flow
cytometry showed similar proportions of infiltratingmacrophages at 24 h (D) and T cells at 2 d (E), aswell asmicroglial expansion
at 5 d (F ). Results are expressed as mean SE. NS, Not statistically significant. *p 0.05.
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erating axons. Enhanced capacity for response may also occur
during motor neuron degeneration or after pilocarpine-induced
seizures, in which microglial upregulation of TLR2 has been de-
scribed (Nguyen et al., 2001; Turrin and Rivest, 2004).
Several endogenous TLR2 ligands have been proposed, in-
cluding heat shock proteins, necrotic cells, fatty acids, and the
transcription factor high mobility group box 1 (Li et al., 2001;
Asea et al., 2002; Gordon, 2002; Lee et al., 2004; Tsan and Gao,
2004; Rifkin et al., 2005). Release of such “danger signals” (Matz-
inger, 2002) from injured axons may initiate the innate CNS
response. The lipid-rich CNS environment is a likely source of
potential ligands for TLR2, most TLR ligands being strongly hy-
drophobic (Seong and Matzinger, 2004). Concern over endo-
toxin contamination hasmade it difficult to conclusively demon-
strate a role for heat shock proteins in endogenous TLR signaling
(Tsan andGao, 2004). Thiswas not a factor in ourmodel, because
CNS responses were similar in TLR4-defective mice and wild-
type controls. Although it is difficult to completely rule out trace
amounts of contaminants carried into theCNS,we feel that this is
not a concern. The innate responses that we measured were
distal from the actual site of tissue injury, and remained pro-
tected by the blood–brain barrier (Fagan and Gage, 1994;
Jensen et al., 1997).
There is growing appreciation that TLRs play pathogen-
independent roles. TLR2 affected ventricular remodeling after
myocardial infarction (Shishido et al., 2003) and TLR4 regulated
behavioral hypersensitivity in models of painful neuropathy
(Tanga et al., 2005) and the inflammatory response to liver isch-
emia/reperfusion (Zhai et al., 2004). Evolutionary forerunners of
TLRs in Drosophila have endogenous roles in dorsoventral pat-
terning and neural functions; few are implicated in generation of
immune response (Brennan and Anderson, 2004). The concept
of pattern recognition may extend to host-derived ligands (Gor-
don, 2002). Endogenous TLR2 signaling is now shown to influ-
ence responses to CNS injury, in addition to its well established
role in protecting against infection.
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